Heterocyclic compound
AssigneeTakeda Pharmaceutical Company Limited
InventorsZenichi Ikeda, Minoru Sasaki, Keiko Kakegawa, Fumiaki Kikuchi, Yoichi Nishikawa
Life of this patent
Estimating the term…
Abstract
A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.
Claims3
A compound which is (5R)-3-(3-((4-Carbamimidamidobenzoyl)oxy)phenyl)-5-(carboxymethyl)-4, 5-dihydro-1,2-oxazole-5-carboxylic acid or a salt thereof.
A compound which is (5S)-3-(3-((4-Carbamimidamidobenzoyl)oxy)phenyl)-5-(carboxymethyl)-4, 5-dihydro-1,2-oxazole-5-carboxylic acid or a salt thereof.
A compound which is 2,2′-(3-(3-((4-Carbamimidamidobenzoyl)oxy)phenyl)-4,5-dihydro-1,2-oxazole-5,5-diyl)diacetic acid or a salt thereof.
Dependencies are inferred from the claim text.